About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker BSX

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Aug 25, 2026Susan E. Morano
Director
BSX
Boston Scientific Corporation
Buy2,040$49.22$100.4K BuyForm 4 ↗
Aug 5, 2026David C. Habiger
Director
BSX
Boston Scientific Corporation
Buy2,100$47.59$99.9K BuyForm 4 ↗
Aug 4, 2026David C. Habiger
Director
BSX
Boston Scientific Corporation
Buy140$48.59$6,803 BuyForm 4 ↗
Aug 3, 2026David C. Habiger
Director
BSX
Boston Scientific Corporation
Buy1,042$48.07$50.1K BuyForm 4 ↗
Aug 3, 2026Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Buy186,240$48.33$9.0M BuyForm 4 ↗
Jul 31, 2026Edward J. Ludwig
Director
BSX
Boston Scientific Corporation
Buy5,000$45.48$227.4K BuyForm 4 ↗
May 20, 2026Cheryl Pegus
Director
BSX
Boston Scientific Corporation
Buy1,770$56.49$100.0K BuyForm 4 ↗
May 20, 2026Edward J. Ludwig
Director
BSX
Boston Scientific Corporation
Buy3,580$56.68$202.9K BuyForm 4 ↗
May 20, 2026David C. Habiger
Director
BSX
Boston Scientific Corporation
Buy2,250$55.92$125.8K BuyForm 4 ↗
May 19, 2026David C. Habiger
Director
BSX
Boston Scientific Corporation
Buy2,200$56.95$125.3K BuyForm 4 ↗
Feb 2, 2026Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale159,701$93.49$14.9M SaleForm 4 ↗
Feb 2, 2026Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale1,200$94.06$112.9K SaleForm 4 ↗
Dec 1, 2025Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
BSX
Boston Scientific Corporation
Sale17,313$101.55$1.8M SaleForm 4 ↗
Nov 6, 2025Ellen M. Zane
Director
BSX
Boston Scientific Corporation
Sale12,891$98.28$1.3M SaleForm 4 ↗
Nov 3, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale29,472$99.14$2.9M SaleForm 4 ↗
Nov 3, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale16,928$99.76$1.7M SaleForm 4 ↗
Nov 3, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale3,600$100.75$362.7K SaleForm 4 ↗
Oct 28, 2025Ellen M. Zane
Director
BSX
Boston Scientific Corporation
Sale2,901$102.24$296.6K SaleForm 4 ↗
Oct 27, 2025Ellen M. Zane
Director
BSX
Boston Scientific Corporation
Sale9,990$101.13$1.0M SaleForm 4 ↗
Oct 1, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale41,755$98.38$4.1M SaleForm 4 ↗
Oct 1, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale8,245$98.91$815.5K SaleForm 4 ↗
Sep 2, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale28,170$105.85$3.0M SaleForm 4 ↗
Sep 2, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale21,830$104.89$2.3M SaleForm 4 ↗
Aug 1, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale50,000$104.63$5.2M SaleForm 4 ↗
Aug 1, 2025Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
BSX
Boston Scientific Corporation
Sale17,313$104.63$1.8M SaleForm 4 ↗
Jul 29, 2025Yoshiaki Fujimori
Director
BSX
Boston Scientific Corporation
Sale2,901$106.99$310.4K SaleForm 4 ↗
Jul 25, 2025Edward J. Ludwig
Director
BSX
Boston Scientific Corporation
Sale4,000$106.03$424.1K SaleForm 4 ↗
Jul 1, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale50,000$106.97$5.3M SaleForm 4 ↗
Jun 4, 2025Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
BSX
Boston Scientific Corporation
Sale56,372$102.88$5.8M SaleForm 4 ↗
Jun 2, 2025Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale89,921$103.39$9.3M SaleForm 4 ↗
Jun 2, 2025Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale74,522$104.05$7.8M SaleForm 4 ↗
May 29, 2025Edward J. Ludwig
Director
BSX
Boston Scientific Corporation
Sale4,000$104.59$418.4K SaleForm 4 ↗
May 21, 2025Vance R. Brown
SVP, GC and Corp. Secretary
BSX
Boston Scientific Corporation
Sale4,826$106.42$513.6K SaleForm 4 ↗
May 5, 2025John Bradley Sorenson
EVP, Global Operations
BSX
Boston Scientific Corporation
Sale4,572$104.54$478.0K SaleForm 4 ↗
May 1, 2025Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale91,282$102.13$9.3M SaleForm 4 ↗
May 1, 2025Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale73,161$102.92$7.5M SaleForm 4 ↗
May 1, 2025Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
BSX
Boston Scientific Corporation
Sale17,314$102.06$1.8M SaleForm 4 ↗
Apr 21, 2025Vance R. Brown
SVP, GC and Corp. Secretary
BSX
Boston Scientific Corporation
Sale4,826$95.09$458.9K SaleForm 4 ↗
Apr 1, 2025Michael F. Mahoney
Chairman, President & CEO, Director
BSX
Boston Scientific Corporation
Sale164,442$100.01$16.4M SaleForm 4 ↗
Mar 21, 2025Vance R. Brown
SVP, GC and Corp. Secretary
BSX
Boston Scientific Corporation
Sale4,826$100.85$486.7K SaleForm 4 ↗
Mar 4, 2025Emily Woodworth
SVP, Global Controller and CAO
BSX
Boston Scientific Corporation
Sale482$104.63$50.4K SaleForm 4 ↗
Mar 3, 2025Emily Woodworth
SVP, Global Controller and CAO
BSX
Boston Scientific Corporation
Sale7,149$104.97$750.4K SaleForm 4 ↗
Feb 28, 2025Emily Woodworth
SVP, Global Controller and CAO
BSX
Boston Scientific Corporation
Sale9,887$101.13$999.9K SaleForm 4 ↗
Feb 25, 2025Jeffrey B. Mirviss
EVP&Pres, Periph Intervent
BSX
Boston Scientific Corporation
Sale2,688$104.00$279.6K SaleForm 4 ↗
Feb 24, 2025Jeffrey B. Mirviss
EVP&Pres, Periph Intervent
BSX
Boston Scientific Corporation
Sale4,675$104.25$487.4K SaleForm 4 ↗
Feb 24, 2025Ellen M. Zane
Director
BSX
Boston Scientific Corporation
Sale13,586$104.23$1.4M SaleForm 4 ↗
Feb 21, 2025Vance R. Brown
SVP, GC and Corp. Secretary
BSX
Boston Scientific Corporation
Sale4,826$104.64$505.0K SaleForm 4 ↗
Feb 19, 2025John Bradley Sorenson
EVP, Global Operations
BSX
Boston Scientific Corporation
Sale3,303$105.19$347.4K SaleForm 4 ↗
Feb 19, 2025Jeffrey B. Mirviss
EVP&Pres, Periph Intervent
BSX
Boston Scientific Corporation
Sale1,510$105.35$159.1K SaleForm 4 ↗
Feb 19, 2025Daniel J. Brennan
EVP and CFO
BSX
Boston Scientific Corporation
Sale67,333$105.24$7.1M SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:08 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances